1. Home
  2. Labeler Index
  3. Pfizer Laboratories Div Pfizer Inc
  4. 0069-5321
  5. NDC Package Code: 0069-5321-30 Paxlovid

NDC Package 0069-5321-30 Paxlovid

Nirmatrelvir And Ritonavir Kit - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0069-5321-30
Package Description:
10 BLISTER PACK in 1 CARTON / 1 KIT in 1 BLISTER PACK (0069-5321-03) * 2 TABLET, FILM COATED in 1 BLISTER PACK (0069-2085-02) * 1 TABLET, FILM COATED in 1 BLISTER PACK (0069-1735-11)
Product Code:
0069-5321
Proprietary Name:
Paxlovid
Non-Proprietary Name:
Nirmatrelvir And Ritonavir
Usage Information:
PAXLOVID is indicated for the treatment of mild-to-moderate coronavirus disease 2019 (COVID-19) in adults who are at high risk for progression to severe COVID-19, including hospitalization or death.
11-Digit NDC Billing Format:
00069532130
NDC to RxNorm Crosswalk:
  • RxCUI: 2587897 - nirmatrelvir 150 MG Oral Tablet
  • RxCUI: 2587898 - {20 (nirmatrelvir 150 MG Oral Tablet) / 10 (ritonavir 100 MG Oral Tablet) } Pack
  • RxCUI: 2587898 - nirmatrelvir 300 MG ; ritonavir 100 MG Daily Dose Pack
  • RxCUI: 2587898 - nirmatrelvir 150 MG Oral Tablet (20) / ritonavir 100 MG Oral Tablet (10) 5-Day Pack
  • RxCUI: 2587899 - {20 (nirmatrelvir 150 MG Oral Tablet) / 10 (ritonavir 100 MG Oral Tablet) } Pack [Paxlovid 5-Day]
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Pfizer Laboratories Div Pfizer Inc
    Dosage Form:
    Kit - A packaged collection of related material.
    Sample Package:
    No
    FDA Application Number:
    NDA217188
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    10-18-2023
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0069-5321-30?

    The NDC Packaged Code 0069-5321-30 is assigned to a package of 10 blister pack in 1 carton / 1 kit in 1 blister pack (0069-5321-03) * 2 tablet, film coated in 1 blister pack (0069-2085-02) * 1 tablet, film coated in 1 blister pack (0069-1735-11) of Paxlovid, a human prescription drug labeled by Pfizer Laboratories Div Pfizer Inc. The product's dosage form is kit and is administered via form.

    Is NDC 0069-5321 included in the NDC Directory?

    Yes, Paxlovid with product code 0069-5321 is active and included in the NDC Directory. The product was first marketed by Pfizer Laboratories Div Pfizer Inc on October 18, 2023 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 0069-5321-30?

    The 11-digit format is 00069532130. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20069-5321-305-4-200069-5321-30